Positions

Overview

  • Dr. Christina Muzny obtained her medical degree at the Texas A&M University Health Sciences Center College of Medicine. She subsequently completed an internal medicine residency and an infectious diseases fellowship at the University of Mississippi Medical Center prior to joining the infectious diseases faculty at the University of Alabama at Birmingham (UAB) in 2010. Dr. Muzny currently has R01 funding from the National Institute of Allergy and Infectious Diseases to study the pathogenesis of bacterial vaginosis. She has recently participated in multiple clinical trials regarding use of 5-nitroimidazoles, including secnidazole, for the treatment of vaginal trichomoniasis in women. She is currently a tenured Associate Professor in the Division of Infectious Diseases at UAB with a secondary appointment in Epidemiology, a teaching faculty for the Alabama-North Carolina STD/HIV Prevention Training Center, and an Associate Scientist for the UAB Center for AIDS Research.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2023 Bacterial Vaginosis in Postmenopausal WomenCurrent Infectious Disease Reports.  25:7-15. 2023
    2022 Answer to Photo Quiz: a Woman with a Pruritic Rash and Unilateral Vision LossJournal of Clinical Microbiology.  60. 2022
    2022 Assessing recovery rates of distinct exogenous controls for gDNA extraction efficiency using phenol-chloroform or silica-column based extractionsJournal of Microbiological Methods.  203. 2022
    2022 DNA extraction leads to bias in bacterial quantification by qPCRApplied Microbiology and Biotechnology.  106:7993-8006. 2022
    2022 Photo Quiz: a Woman with a Pruritic Rash and Unilateral Vision LossJournal of Clinical Microbiology.  60. 2022
    2022 Sexually transmitted infection screening to prevent adverse birth and newborn outcomes: study protocol for a randomized-controlled hybrid-effectiveness trialTrials.  23. 2022
    2022 Sexually transmitted infections and female reproductive healthNature Microbiology.  7:1116-1126. 2022
    2022 Diagnosis and Management of Bacterial Vaginosis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment GuidelinesClinical Infectious Diseases.  74:S144-S151. 2022
    2022 Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment GuidelinesClinical Infectious Diseases.  74:S152-S161. 2022
    2022 IgG4-Related Disease Masquerading as Culture-Negative Endocarditis 2022
    2022 Secnidazole for Trichomoniasis in Women and MenSexual Medicine Reviews.  10:255-262. 2022
    2022 The Role of Antimicrobial Resistance in Refractory and Recurrent Bacterial Vaginosis and Current Recommendations for TreatmentAntibiotics.  11. 2022
    2022 The Role of Antimicrobial Resistance in Refractory and Recurrent Bacterial Vaginosis and Current Recommendations for Treatment 2022
    2022 A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in WomenSexually Transmitted Diseases.  49:231-236. 2022
    2022 Association of Bacterial Vaginosis with Higher Vaginal Indole LevelsSexually Transmitted Diseases.  49:E53-E55. 2022
    2022 Human Immunodeficiency Virus/Sexually Transmitted Infection Testing Preferences for Young Black Men Who Have Sex with Men in the Southeastern United States: Implications for a Post-COVID-19 EraSexually Transmitted Diseases.  49:208-215. 2022
    2022 Anatomical and sexual health considerations among transfeminine individuals who have undergone vaginoplasty: A reviewInternational Journal of STD and AIDS.  33:106-113. 2022
    2022 Crystal Violet Staining Alone Is Not Adequate to Assess Synergism or Antagonism in Multi-Species Biofilms of Bacteria Associated With Bacterial VaginosisFrontiers in Cellular and Infection Microbiology.  11. 2022
    2022 "It's behaviors, not identity": Attitudes and beliefs related to HIV risk and pre-exposure prophylaxis among transgender women in the Southeastern United StatesPLoS One.  17. 2022
    2022 Secnidazole: a treatment for trichomoniasis in adolescents and adultsExpert Review of Anti-infective Therapy.  20:1067-1076. 2022
    2021 Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatmentBMC Medicine.  19. 2021
    2021 A New PNA-FISH Probe Targeting Fannyhessea vaginaeFrontiers in Cellular and Infection Microbiology.  11. 2021
    2021 Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysisBJOG: an International Journal of Obstetrics and Gynaecology.  128:1907-1915. 2021
    2021 Diagnosis of Vaginitis: New Thinking for a New EraPopulation Health Management.  24:616-621. 2021
    2021 Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment StudyClinical Infectious Diseases.  73:E1282-E1289. 2021
    2021 Epidemiology, Natural History, Diagnosis, and Treatment of Trichomonas vaginalis in MenClinical Infectious Diseases.  73:1119-1124. 2021
    2021 A new treatment option for trichomoniasis: Single-dose secnidazoleContemporary OB/GYN.  66. 2021
    2021 Management of Trichomoniasis in the Setting of 5-Nitroimidazole HypersensitivitySexually Transmitted Diseases.  48:E111-E115. 2021
    2021 Treatment of Male Sexual Partners of Women with Bacterial Vaginosis: A Randomized, Double-Blind, Placebo-Controlled TrialClinical Infectious Diseases.  73:E672-E679. 2021
    2021 Obesity is associated with lower bacterial vaginosis prevalence in menopausal but not pre-menopausal women in a retrospective analysis of the Women’s Interagency HIV StudyPLoS One.  16. 2021
    2021 Atopobium vaginae and prevotella bivia are able to incorporate and influence gene expression in a pre-formed gardnerella vaginalis biofilmPathogens.  10:1-16. 2021
    2021 Sexually Transmitted Infections Treatment Guidelines, 2021 2021
    2020 Asymptomatic Bacterial Vaginosis: to Treat or Not to Treat?Current Infectious Disease Reports.  22. 2020
    2020 Use of a Novel Couples' Verification Tool in a Male Partner Treatment Study of Women with Recurrent Bacterial VaginosisSexually Transmitted Diseases.  47:E58-E61. 2020
    2020 A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Trichomonas vaginalis 2020
    2020 A Narrative Review of Current Challenges in the Diagnosis and Management of Bacterial VaginosisSexually Transmitted Diseases.  47:441-446. 2020
    2020 Prevalence of Sexually Transmitted Infections and Human Immunodeficiency Virus in Transgender Persons: A Systematic ReviewTransgender Health.  5:90-103. 2020
    2020 Persistent Chlamydia trachomatis, Neisseria gonorrhoeae or Trichomonas vaginalis positivity after treatment among human immunodeficiency virus-infected pregnant women, South AfricaInternational Journal of STD and AIDS.  31:294-302. 2020
    2020 Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosisCurrent Opinion in Infectious Diseases.  33:59-65. 2020
    2020 Sexually transmitted infections and sexual behaviors of men who have sex with men in an American Deep South PrEP clinicInternational Journal of STD and AIDS.  31:127-135. 2020
    2020 Updates in trichomonas treatment including persistent infection and 5-nitroimidazole hypersensitivityCurrent Opinion in Infectious Diseases.  33:73-77. 2020
    2020 Quantitative evaluation on the challenges and opportunities in the recruitment of young Black men who have sex with men for sexual health research in the southern USSexual Health.  17:87-90. 2020
    2020 Sexually Transmitted Infections in Pregnancy and Reproductive Health: Proceedings of the STAR Sexually Transmitted Infection Clinical Trial Group Programmatic MeetingSexually Transmitted Diseases.  47:5-11. 2020
    2019 Trichomonas vaginalis Virus among Women with Trichomoniasis and Associations with Demographics, Clinical Outcomes, and Metronidazole ResistanceClinical Infectious Diseases.  69:2170-2176. 2019
    2019 An Updated Conceptual Model on the Pathogenesis of Bacterial VaginosisJournal of Infectious Diseases.  220:1399-1405. 2019
    2019 Incubation period and risk factors support sexual transmission of bacterial vaginosis in women who have sex with womenSexually Transmitted Infections.  95:511-515. 2019
    2019 Pharmacokinetic and Pharmacodynamic Effects of Metronidazole May Account for the Superior Efficacy of Multidose Therapy among Women with TrichomoniasisSexually Transmitted Diseases.  46:751-752. 2019
    2019 Is It Time to Stop Using Single-dose Oral Metronidazole for the Treatment of Trichomoniasis in Women?Sexually Transmitted Diseases.  46:E57-E59. 2019
    2019 Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification TestingSexually Transmitted Diseases.  46:312-316. 2019
    2019 Trichomonas vaginalis virus: a review of the literatureInternational Journal of STD and AIDS.  30:496-504. 2019
    2019 Incidence and predictors of reinfection with trichomoniasis based on nucleic acid amplification testing results in HIV-infected patientsInternational Journal of STD and AIDS.  30:344-352. 2019
    2019 In Silico and Experimental Evaluation of Primer Sets for Species-Level Resolution of the Vaginal Microbiota Using 16S Ribosomal RNA Gene SequencingJournal of Infectious Diseases.  219:305-314. 2019
    2019 Recent advances in the epidemiology, diagnosis, and management of trichomonas vaginalis infection [version 1; peer review: 2 approved]F1000Research.  8. 2019
    2019 Treatment recommendations for trichomoniasis in womenLancet Infectious Diseases.  19:20-21. 2019
    2018 Do young black men who have sex with men in the deep south prefer traditional over alternative STI testing?PLoS One.  13. 2018
    2018 Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trialLancet Infectious Diseases.  18:1251-1259. 2018
    2018 Identification of Key Bacteria Involved in the Induction of Incident Bacterial Vaginosis: A Prospective StudyJournal of Infectious Diseases.  218:966-978. 2018
    2018 Why does trichomonas vaginalis continue to be a "neglected" sexually transmitted infection?Clinical Infectious Diseases.  67:218-220. 2018
    2018 Psychosocial stressors and sexual health among Southern African American women who have sex with womenLGBT Health.  5:234-241. 2018
    2018 Is There a Continuum of Risk for Sexually Transmitted Infections among African American Women?Sexually Transmitted Diseases.  45:e20-e22. 2018
    2018 Reverse syphilis screening algorithm fails to demonstrate cost effectiveness in persons living with HIVInternational Journal of STD and AIDS.  29:563-567. 2018
    2018 Comparisons of vaginal flora patterns among sexual behaviour groups of women: Implications for the pathogenesis of bacterial vaginosisSexual Health.  15:61-67. 2018
    2017 Budgetary impact of compliance with sti screening guidelines in persons living with HIV 2017
    2017 Sexually Transmitted Infection Risk among Women Is Not Fully Explained by Partner NumbersSouthern Medical Journal.  110:161-167. 2017
    2017 Sexual orientation and sexual health services utilization among women in the United StatesPreventive Medicine.  95:74-81. 2017
    2017 Trichomonas vaginalis treated with boric acid in a metronidazole allergic femaleSexually Transmitted Diseases.  44:120. 2017
    2016 Screening for Sexually Transmitted Infections in Persons Living With Human Immunodeficiency Virus (HIV) Leads to Significant Financial Losses for a Healthcare SystemOpen Forum Infectious Diseases.  3:1680. 2016
    2016 Sexual Orientation and Sexual and Reproductive Health among African American Sexual Minority Women in the U.S. SouthWomen's Health Issues.  26:612-621. 2016
    2016 Chlamydia trachomatis infection in African American women who exclusively have sex with womenInternational Journal of STD and AIDS.  27:978-983. 2016
    2016 Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment OptionsAnnals of Pharmacotherapy.  50:747-757. 2016
    2016 Pathogenesis of Bacterial Vaginosis: Discussion of Current HypothesesJournal of Infectious Diseases.  214:S1-S5. 2016
    2016 Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV ClinicSexually Transmitted Diseases.  43:483-488. 2016
    2015 Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal InfectionsClinical Infectious Diseases.  61:601-606. 2015
    2015 Accuracy of self-report of sexual activity among adolescent girls: Implications for interpretation of vaginal flora patternsmBio.  6:1-2. 2015
    2015 Editorial commentary: Women who have sex with women: A unique population for studying the pathogenesis of bacterial vaginosisClinical Infectious Diseases.  60:1054-1056. 2015
    2014 Association between BVAB1 and high Nugent scores among women with bacterial vaginosisDiagnostic Microbiology and Infectious Disease.  80:321-323. 2014
    2014 Reply to hickey and forneyJournal of Infectious Diseases.  210:1683-1684. 2014
    2014 Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinicClinical Infectious Diseases.  59:834-841. 2014
    2014 Role of Gardnerella vaginalis in the pathogenesis of bacterial vaginosis: A conceptual modelJournal of Infectious Diseases.  210:338-343. 2014
    2014 Antibiotic hypersensitivity reactions and approaches to desensitizationClinical Infectious Diseases.  58:1140-1148. 2014
    2014 Families of choice and noncollegiate sororities and fraternities among lesbian and bisexual african-American women in a southern community: Implications for sexual and reproductive health researchSexual Health.  11:24-30. 2014
    2014 Lack of evidence for sexual transmission of genital Candida species among women who have sex with women: A mixed methods studySexually Transmitted Infections.  90:165-170. 2014
    2014 Lower sexually transmissible infection prevalence among lifetime exclusive women who have sex with women compared with women who have sex with women and menSexual Health.  11:592-593. 2014
    2014 Lymphogranuloma venereum proctitis and clostridium difficile colitis in an HIV-infected patientInfectious Diseases in Clinical Practice.  22. 2014
    2014 Rickettsia parkeri: Eschar diagnosisJournal of the American Academy of Dermatology.  71. 2014
    2014 Sexual partnership characteristics of African American women who have sex with women; impact on sexually transmitted infection riskSexually Transmitted Diseases.  41:611-617. 2014
    2014 Suspected heterosexual transmission of bacterial vaginosis without seminal fluid exposureSexually Transmitted Diseases.  41:58-60. 2014
    2013 Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosisPLoS One.  8. 2013
    2013 Diagnostic rates differ on the basis of the number of read days with the use of the Inpouch culture system for Trichomonas Vaginalis screeningJournal of Clinical Microbiology.  51:3875-3876. 2013
    2013 Bacterial vaginosis among African American women who have sex with womenSexually Transmitted Diseases.  40:751-755. 2013
    2013 The clinical spectrum of Trichomonas vaginalis infection and challenges to managementSexually Transmitted Infections.  89:423-425. 2013
    2013 Trichomonas vaginalis infection among women receiving gynaecological care at an Alabama HIV ClinicSexually Transmitted Infections.  89:514-518. 2013
    2013 Sexual behaviors, perception of sexually transmitted infection risk, and practice of safe sex among southern african american women who have sex with womenSexually Transmitted Diseases.  40:395-400. 2013
    2013 Misperceptions regarding protective barrier method use for safer sex among African-American women who have sex with womenSexual Health.  10:138-141. 2013
    2013 Gardnerella vaginalis: Still a prime suspect in the pathogenesis of bacterial vaginosisCurrent Infectious Disease Reports.  15:130-135. 2013
    2012 Genetic characterization of Trichomonas vaginalis isolates by use of multilocus sequence typingJournal of Clinical Microbiology.  50:3293-3300. 2012
    2012 Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: Successful treatment with boric acidSexual Health.  9:389-391. 2012
    2012 A fatal case of kaposi sarcoma due to immune reconstitution inflammatory syndromeAmerican Journal of the Medical Sciences.  343:421-425. 2012
    2012 Genotypic characterization of Trichomonas vaginalis isolates among women who have sex with women in sexual partnerships.Sexually Transmitted Diseases.  39:556-558. 2012
    2012 Hansen's disease (Leprosy): Current and future pharmacotherapy and treatment of disease-related immunologic reactions 2012
    2011 Sexually transmitted infections and risk behaviors among African American women who have sex with women: Does sex with men make a difference?Sexually Transmitted Diseases.  38:1118-1125. 2011
    2011 Slowly progressive annular skin lesions in an elderly patient.Clinical Infectious Diseases.  52. 2011
    2010 Enterococcus faecium vertebral osteomyelitis and its association with infective endocarditisInfectious Diseases in Clinical Practice.  18:80-82. 2010
    2009 Vulvar vaccinia infection after sexual contact with a smallpox vaccineeAmerican Journal of the Medical Sciences.  337:289-291. 2009
    2008 Pneumococcal septic arthritis as the initial presentation of multiple myelomaInternational Journal of Laboratory Hematology.  30:82-83. 2008
    2008 Vomiting and diarrhea in a 51-year-old woman with splenectomyChest.  134:438-441. 2008
    2005 Mystery in the basement.Journal of the Mississippi State Medical Association.  46:198-201. 2005

    Chapter

    Year Title Altmetric
    2021 Trichomoniasis 2021
    2021 Trichomoniasis 2021
    2017 Trichomonas vaginalis Infections.  125-140. 2017
    2013 Vaginal Infections.  473-483. 2013
    2012 Vaginal Infections.  473-483. 2012

    Research Overview

  • Pathogenesis, epidemiology, diagnosis, treatment, and prevention of bacterial vaginosis and trichomoniasis
  • Principal Investigator On

  • African American Lesbian Families, Sororities and Fraternities and Their Role in the Promotion of Sexual Health and Prevention of Sexually Transmitted Infections in LGBT Communities  awarded by UNIVERSITY OF MISSISSIPPI MEDICAL CENTER
  • Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes  awarded by University of California, Los Angeles
  • Clinical Study of STI Screening to Prevent Adverse Birth and Newborn Outcomes  awarded by University of Southern California
  • Identification of Trichomonas Vaginalis Resistance Targets to Inform Future Drug Development  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Microbial Interactions between Gardnerella, Prevotella, and Atopobium Prior to Incident Bacterial Vaginosis  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Pathogenesis of Bacterial Vaginosis in Women Who Have Sex with Women  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Private Grant  awarded by LUPIN INC.
  • Private Grant  awarded by ABBOTT MOLECULAR
  • Private Grant  awarded by LUPIN INC.
  • Private Grant  awarded by VISBY MEDICAL ^
  • Service Agreement with University of Arizona College of Medicine-Phoenix  awarded by University of Arizona
  • Sexually Transmitted Infections Among African American Women Who Have Sex With Women  awarded by American Sexually Transmitted Disease Association
  • The Impact of Testosterone Use on the Vaginal Microbiota in Transgender Men, including Susceptibility to Bacterial Vaginosis  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Trichomonas Vaginalis Repeat Infections Among HIV-Negative Women  awarded by TULANE UNIVERSITY
  • Trichomonas Vaginalis Repeat Infections among Men Who Have Sex with Women  awarded by TULANE UNIVERSITY
  • Investigator On

  • A Double-Blind Randomized Trial of Monthly Treatment with Topical Metronidazole and Miconazole Co-formulated Pessaries vs Placebo for Preventing Vaginal Infections in HIV-Seronegative Women DMID #09-0070  awarded by University of California, San Francisco
  • JCDH Contract NO: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • JCDH Contract No DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • JCDH Contract No: DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • Jefferson County Department of Health Contract No. DC-29  awarded by JEFFERSON COUNTY DEPARTMENT OF HEALTH
  • Mechanisms and Correlates of Immune Protection Against Genital Chlamydia in Humans  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Private Grant  awarded by SANOFI PASTEUR LIMITED
  • Private Grant  awarded by BD DIAGNOSTICS
  • Private Grant  awarded by BD DIAGNOSTICS
  • Private Grant  awarded by MEDICIS PHARMACEUTICAL CORPORATION
  • Private Grant  awarded by BD DIAGNOSTICS
  • Private Grant  awarded by ACTIVBIOTICS, INC.
  • Private Grant  awarded by COPAN DIAGNOSTICS, INC
  • Private Grant  awarded by BD DIAGNOSTICS
  • Private Grant  awarded by GEN-PROBE, INC.
  • Private Grant  awarded by GEN-PROBE, INC.
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC.
  • Private Grant  awarded by BIOHELIX CORPORATION
  • Private Grant  awarded by CEPHEID
  • Private Grant  awarded by WATSON LABORATORIES, INC.
  • Private Grant  awarded by BD DIAGNOSTICS
  • Private Grant  awarded by CEPHEID
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC
  • Private Grant  awarded by CEPHEID
  • Private Grant  awarded by STARPHARMA
  • Private Grant  awarded by RHEONIX, INC.
  • Private Grant  awarded by VIAMET PHARMACEUTICALS, INC. - NEW
  • Private Grant  awarded by HOLOGIC, INC.
  • Private Grant  awarded by ELITECH GROUP MOLECULAR
  • Private Grant  awarded by BD DIAGNOSTICS
  • Private Grant  awarded by ALFA-WASSERMAN, INC.
  • Private Grant  awarded by CURATEK PHARMACEUTICALS
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC
  • Private Grant  awarded by BECKMAN COULTER, INC.
  • Private Grant  awarded by FLORA BIOSCIENCE
  • Private Grant  awarded by SYMBIOMIX THERAPEUTICS, LLC
  • Private Grant  awarded by HOLOGIC, INC.
  • Private Grant  awarded by QUIDEL CORPORATION
  • Private Grant  awarded by CIDARA THERAPEUTICS, INC. - NEW
  • Private Grant  awarded by HOLOGIC, INC.
  • Private Grant  awarded by LABORATORY CORPORATION OF AMERICA HOLDINGS
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY
  • Private Grant  awarded by CLICK DIAGNOSTICS
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC.
  • Private Grant  awarded by ATLAS GENETICS
  • Private Grant  awarded by LUMINEX CORPORATION
  • Private Grant  awarded by HOLOGIC, INC.
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC.
  • Private Grant  awarded by SPEEDX PTY. LTD.
  • Private Grant  awarded by ABBOTT MOLECULAR
  • Private Grant  awarded by LUMINEX CORPORATION
  • Private Grant  awarded by CEPHEID
  • Private Grant  awarded by ABBOTT MOLECULAR
  • Private Grant  awarded by NEUMODX MOLECULAR
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY
  • Private Grant  awarded by SPEEDX PTY. LTD.
  • Private Grant  awarded by BIOFIRE DIAGNOSTICS^
  • Private Grant  awarded by Gilead Sciences ^
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY
  • Private Grant  awarded by BIOFIRE DIAGNOSTICS^
  • Private Grant  awarded by RHEONIX, INC.
  • Private Grant  awarded by ROCHE MOLECULAR SYSTEMS, INC.
  • Private Grant  awarded by CUE HEALTH INC.
  • Private Grant  awarded by BIOFIRE DIAGNOSTICS^
  • Private Grant  awarded by BECTON DICKINSON AND COMPANY
  • Rectal and Oropharyngeal Swabs to Diagnose Gonococcal and Chlamydial Infection in Men and Women  awarded by University of California, San Francisco
  • STD/HIV Prevention Training Center  awarded by CDC - NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION
  • Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing: Concurrence in Non-Clinical Settings vs. Clinical Settings  awarded by University of California, San Francisco
  • The UAB STI CRC - Project 2: Strain Diversity among Gardnerella: Association with Progression to BV  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • The UAB Sexually Transmitted Infections Cooperative Research Centers (STI CRC)  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS
  • Education And Training

  • University of Mississippi Medical Center, Internship
  • University of Mississippi Medical Center, Residency
  • University of Mississippi Medical Center, Postdoctoral Fellowship
  • Master of Science in Health Professions and Related Clinical Sciences, University of Alabama at Birmingham 2017
  • Doctor of Medicine, Texas A&M University System Health Science Center 2003
  • Bachelor of Arts in Biology, University of Texas System : Austin 1998
  • Full Name

  • Christina Muzny